HSIC - Henry Schein, Inc.
NASDAQ
->
Healthcare
->
Medical Distribution
Melville,
United States
Type: Equity
HSIC price evolution
HSIC
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 30 Apr 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $138 | $159 | $171 | |
| Short term investments | ||||
| Net receivables | $1660 | $1559 | $1644 | $1863 |
| Inventory | $1754 | $1657 | $1686 | $1815 |
| Total current assets | $4147 | $3941 | $4078 | $4488 |
| Long term investments | $502 | $503 | $471 | |
| Property, plant & equipment | $844 | $822 | $814 | $823 |
| Goodwill & intangible assets | $4986 | $4750 | $4791 | |
| Total noncurrent assets | $6310 | $6067 | $6085 | |
| Total investments | $502 | $503 | $471 | |
| Total assets | $10605 | $10251 | $10145 | $10573 |
| Current liabilities | ||||
| Accounts payable | $1026 | $867 | $879 | $1020 |
| Deferred revenue | ||||
| Short long term debt | $686 | $442 | $494 | |
| Total current liabilities | $2929 | $2549 | $2334 | $2683 |
| Long term debt | $1906 | $2152 | $2010 | $2247 |
| Total noncurrent liabilities | $2698 | $2776 | $2737 | |
| Total debt | $2838 | $2718 | $2741 | |
| Total liabilities | $7102 | $5247 | $6545 | $5420 |
| Shareholders' equity | ||||
| Retained earnings | $3766 | $3803 | $3838 | $3860 |
| Other shareholder equity | -$264 | -$292 | -$239 | -$206 |
| Total shareholder equity | $3512 | $3600 | $3655 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $171 | $117 | $117.97 | $421.19 |
| Short term investments | ||||
| Net receivables | $1863 | $1442 | $1451.83 | $1424.79 |
| Inventory | $1815 | $1963 | $1861.14 | $1512.5 |
| Total current assets | $4488 | $3988 | $3844.03 | $3791.41 |
| Long term investments | $471 | $472 | $423.87 | $366.44 |
| Property, plant & equipment | $823 | $667 | $691.41 | $630.85 |
| Goodwill & intangible assets | $4791 | $3480 | $3521.78 | $2983.82 |
| Total noncurrent assets | $6085 | $4619 | $4637.06 | $3981.12 |
| Total investments | $471 | $472 | $423.87 | $366.44 |
| Total assets | $10573 | $8607 | $8481.09 | $7772.53 |
| Current liabilities | ||||
| Accounts payable | $1020 | $1004 | $1053.93 | $1005.65 |
| Deferred revenue | ||||
| Short long term debt | $494 | $182 | $137.56 | $247.92 |
| Total current liabilities | $2683 | $2224 | $2306.51 | $2283.1 |
| Long term debt | $2247 | $1040 | $1079.12 | $754.5 |
| Total noncurrent liabilities | $2737 | $1712 | $1498.07 | $1177.35 |
| Total debt | $2741 | $1497 | $1216.68 | $1002.42 |
| Total liabilities | $5420 | $5161 | $3804.59 | $3460.45 |
| Shareholders' equity | ||||
| Retained earnings | $3860 | $3678 | $3595.23 | $3454.83 |
| Other shareholder equity | -$206 | -$233 | -$171.48 | -$108.08 |
| Total shareholder equity | $3655 | $3446 | $3425.13 | $3348.17 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3136 | $3172 | $3017 | |
| Cost of revenue | $2118 | $2160 | $2092 | |
| Gross Profit | $1018 | $1012 | $925 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $781 | $791 | $807 | |
| Total operating expenses | $859 | $862 | $886 | |
| Operating income | $159 | $150 | $39 | |
| Income from continuing operations | ||||
| EBIT | $169 | $155 | $48 | |
| Income tax expense | $33 | $32 | $1 | |
| Interest expense | $32 | $30 | $29 | |
| Net income | ||||
| Net income | $104 | $93 | $18 | |
| Income (for common shares) | $104 | $93 | $18 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12339 | $12647 | $12401.02 | $10119.14 |
| Cost of revenue | $8478 | $8816 | $8728.77 | $7304.8 |
| Gross Profit | $3861 | $3831 | $3672.25 | $2814.34 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2956 | $2771 | $2812.66 | $2246.95 |
| Total operating expenses | $3246 | $3084 | $2820.59 | $2279.04 |
| Operating income | $615 | $747 | $851.66 | $535.3 |
| Income from continuing operations | ||||
| EBIT | $623 | $752 | $856.18 | $540.54 |
| Income tax expense | $120 | $170 | $197.35 | $95.37 |
| Interest expense | $87 | $44 | $27.6 | $41.38 |
| Net income | ||||
| Net income | $416 | $538 | $631.23 | $403.79 |
| Income (for common shares) | $416 | $538 | $631.23 | $403.79 |
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $104 | $93 | $18 | |
| Operating activities | ||||
| Depreciation | $74 | $73 | $68 | |
| Business acquisitions & disposals | -$159 | -$19 | -$285 | |
| Stock-based compensation | $12 | $8 | $1 | |
| Total cash flows from operations | $296 | $197 | -$32 | |
| Investing activities | ||||
| Capital expenditures | -$48 | -$50 | -$79 | |
| Investments | $22 | |||
| Total cash flows from investing | -$372 | -$209 | -$72 | -$327 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$99 | -$74 | -$50 | |
| Net borrowings | $125 | $30 | $450 | |
| Total cash flows from financing | -$306 | -$114 | -$151 | $394 |
| Effect of exchange rate | -$11 | $6 | $14 | -$30 |
| Change in cash and equivalents | -$45 | -$21 | -$12 | $5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $416 | $538 | $631.23 | $403.79 |
| Operating activities | ||||
| Depreciation | $248 | $212 | $209.53 | $185.54 |
| Business acquisitions & disposals | -$949 | -$147 | -$574.65 | -$60.17 |
| Stock-based compensation | $39 | $54 | $78.42 | $8.79 |
| Total cash flows from operations | $500 | $602 | $709.58 | $598.91 |
| Investing activities | ||||
| Capital expenditures | -$187 | -$96 | -$79.02 | -$48.83 |
| Investments | $22 | $9.76 | $12.78 | |
| Total cash flows from investing | -$1135 | -$276 | -$677.22 | -$115.02 |
| Financing activities | ||||
| Dividends paid | -$7.89 | |||
| Sale and purchase of stock | -$249 | -$483 | -$401.21 | -$73.79 |
| Net borrowings | $1050 | $259 | $161.43 | -$68.99 |
| Total cash flows from financing | $701 | -$315 | -$332.96 | -$187.19 |
| Effect of exchange rate | -$12 | -$12 | -$2.63 | $18.38 |
| Change in cash and equivalents | $54 | -$1 | -$303.22 | $315.09 |
News
Fundamentals
| Market cap | $9.01B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 125.15M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.48 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.42 |
| Quick ratio | 0.82 |